Galapagos with €240M, made the Biggest European Biotech IPO ever on NASDAQ

By Lourdes Riquelme

Galapagos has once again made the front page thanks to its unbeaten IPO. The company just raised €240M on Nasdaq, becoming the biggest European biotech IPO ever on the US stock market. The Belgium company just ranked above Cellectis, who, until now, held the biggest European IPO record on Nasdaq. Lire la suite

Source:: Labiotech

Les commentaires sont clos.